Regional chemotherapy for the treatment of breast cancer a review of clinical effectiveness, cost-effectiveness and guidelines
Regional chemotherapy for metastatic cancer is not practiced widely within Canada. The treatment is available at certain institutions for treatment of colorectal cancer that has metastasized to the liver, but it is not available for metastatic breast cancer in Canada due to a lack of evidence from c...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
CADTH
2018, October 12, 2018
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Regional chemotherapy for metastatic cancer is not practiced widely within Canada. The treatment is available at certain institutions for treatment of colorectal cancer that has metastasized to the liver, but it is not available for metastatic breast cancer in Canada due to a lack of evidence from clinical trials. The objective of this report is to summarize the evidence regarding regional chemotherapy for adults with metastatic breast cancer to help address uncertainty about its effectiveness for this indication |
|---|---|
| Physical Description: | 1 PDF file (26 pages) illustrations |